BTC $77,289.08 -0.13%
ETH $2,442.02 +0.07%
BNB $698.85 -0.07%
XRP $1.50 -0.27%
SOL $95.16 +0.72%
TRX $0.3436 -0.45%
DOGE $0.0926 -1.66%
ADA $0.2240 -3.43%
BCH $272.32 -2.86%
LINK $11.47 -2.45%
HYPE $80.95 +1.63%
AAVE $139.75 +10.40%
SUI $0.8346 +0.06%
XLM $0.1976 -0.59%
ZEC $845.35 +0.90%
BTC $77,289.08 -0.13%
ETH $2,442.02 +0.07%
BNB $698.85 -0.07%
XRP $1.50 -0.27%
SOL $95.16 +0.72%
TRX $0.3436 -0.45%
DOGE $0.0926 -1.66%
ADA $0.2240 -3.43%
BCH $272.32 -2.86%
LINK $11.47 -2.45%
HYPE $80.95 +1.63%
AAVE $139.75 +10.40%
SUI $0.8346 +0.06%
XLM $0.1976 -0.59%
ZEC $845.35 +0.90%

The judge ruled that Bitfarms must immediately terminate its "poison pill" strategy aimed at opposing Riot Platforms' acquisition

2024-07-25 13:58:35

ChainCatcher news, the encrypted mining company Riot Platforms stated in a declaration on July 24 that the Ontario Capital Markets Tribunal issued a cease trading order on Bitfarms' poison pill plan, immediately terminating the strategy.

Since June 13, Bitfarms has been opposing Riot Platforms' $950 million acquisition offer, claiming that Riot unfairly undervalued the company. The company adopted a poison pill strategy known as a "rights plan" to attempt to block the acquisition.

Poison pill strategies are typically used by companies to prevent hostile takeovers. Under this strategy, existing shareholders purchase additional shares at a significant discount, diluting the value of the shares held by the acquirer. According to Bitfarms' now-defunct rights plan, if any entity acquires more than 15% of the company's outstanding shares before September 10, Bitfarms will issue new shares to other existing shareholders, thereby reducing that entity's ownership.

app_icon
ChainCatcher Building the Web3 world with innovations.